Results 251 to 260 of about 345,077 (288)
Some of the next articles are maybe not open access.
Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion
Expert Review of Clinical Pharmacology, 2020Objectives: Postmenopausal osteoporosis carries a high risk of fractures, which decrease quality of life and are associated with high morbidity, mortality, and economic burden. The best pharmacological treatment options to manage and prevent osteoporotic
Filippo Migliorini +5 more
semanticscholar +1 more source
Rejuvenation Research, 2020
Postmenopausal osteoporosis, the most common type of primary osteoporosis, poses a significant threat to women's health worldwide. However, detailed molecular mechanism and therapeutic strategy for postmenopausal osteoporosis remain insufficient ...
yin Fu +4 more
semanticscholar +1 more source
Postmenopausal osteoporosis, the most common type of primary osteoporosis, poses a significant threat to women's health worldwide. However, detailed molecular mechanism and therapeutic strategy for postmenopausal osteoporosis remain insufficient ...
yin Fu +4 more
semanticscholar +1 more source
circRNA_0016624 could sponge miR-98 to regulate BMP2 expression in postmenopausal osteoporosis.
Biochemical and Biophysical Research Communications - BBRC, 2019BACKGROUND Circular RNAs (circRNAs) are emerging as important regulators in human disease. The expression profile and mechanism of circRNAs in postmenopausal osteoporosis remains largely unknown.
Long Yu, Yonggang Liu
semanticscholar +1 more source